Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 6, Number 2, February 2008

Free Content Recollections on thrombin generation
pp. 219-226(8)
Author: HEMKER, H. C.

Favourites:
ADD

Free Content Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants
pp. 227-229(3)
Authors: BÜLLER, H. R.; HALPERIN, J. L.; BOUNAMEAUX, H.; PRINS, M.

Favourites:
ADD

Free Content Double-blindness protects scientific validity
pp. 230-231(2)
Authors: FURBERG, C. D.; SOLIMAN, E. Z.

Favourites:
ADD

Free Content Open-label trials and drug registration: a European regulator’s view
pp. 232-234(3)
Authors: CASTEELS, M.; FLAMION, B.

Favourites:
ADD
Favourites:
ADD

Free Content Venous thromboembolism and subsequent short-term risk of an occult cancer
pp. 249-250(2)
Authors: SØRENSEN, H. T.; JOHNSEN, S. P.

Favourites:
ADD

Free Content Clinical outcome in patients with venous thromboembolism and hidden cancer: findings from the RIETE Registry
pp. 251-255(5)
Authors: TRUJILLO-SANTOS, J.; PRANDONI, P.; RIVRON-GUILLOT, K.; ROMÁN, P.; SÁNCHEZ, R.; TIBERIO, G.; MONREAL, M.

Favourites:
ADD

Free Content Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII)
pp. 259-267(9)
Authors: MILLER, G. J.; IRELAND, H. A.; COOPER, J. A.; BAUER, K. A.; MORRISSEY, J. H.; HUMPHRIES, S. E.; ESNOUF, M. P.

Favourites:
ADD

Free Content Thrombin activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children
pp. 268-276(9)
Authors: EMONTS, M.; DE BRUIJNE, E. L. E.; GUIMARÃES, A. H. C.; DECLERCK, P. J.; LEEBEEK, F. W. G.; DE MAAT, M. P. M.; RIJKEN, D. C.; HAZELZET, J. A.; GILS, A.

Favourites:
ADD

Free Content Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A
pp. 277-283(7)
Authors: POWELL, J. S.; NUGENT, D. J.; HARRISON, J. A.; SONI, A.; LUK, A.; STASS, H.; GORINA, E.

Favourites:
ADD

Free Content Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants
pp. 284-290(7)
Authors: PENNING-VAN BEEST, F. J. A.; KOERSELMAN, J.; HERINGS, R. M. C.

Favourites:
ADD

Free Content Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk
pp. 291-296(6)
Authors: BACH, J.; ENDLER, G.; WINKELMANN, B. R.; BOEHM, B. O.; MAERZ, W.; MANNHALTER, C.; HELLSTERN, P.

Favourites:
ADD

Free Content Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review
pp. 297-302(6)
Authors: WARNAAR, N.; MOLENAAR, I. Q.; COLQUHOUN, S. D.; SLOOFF, M. J. H.; SHERWANI, S.; de WOLF, A. M.; PORTE, R. J.

Favourites:
ADD

Free Content Tissue-specific hemostasis: role of tissue factor
pp. 303-305(3)
Author: MACKMAN, N.

Favourites:
ADD

Free Content Expression of human tissue factor under the control of the mouse tissue factor promoter mediates normal hemostasis in knock-in mice
pp. 306-314(9)
Authors: SNYDER, L. A.; RUDNICK, K. A.; TAWADROS, R.; VOLK, A.; TAM, S. H.; ANDERSON, G. M.; BUGELSKI, P. J.; YANG, J.

Favourites:
ADD

Free Content Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies
pp. 315-322(8)
Authors: SCHEIFLINGER, F.; DOCKAL, M.; ROSING, J.; KERSCHBAUMER, R. J.

Favourites:
ADD

Free Content A highly-sensitive plasma von Willebrand factor ristocetin cofactor (VWF:RCo) activity assay by flow cytometry
pp. 323-330(8)
Authors: CHEN, D.; DAIGH, C. A.; HENDRICKSEN, J. I.; PRUTHI, R. K.; NICHOLS, W. L.; HEIT, J. A.; OWEN, W. G.

Favourites:
ADD

Free Content Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura
pp. 331-338(8)
Authors: CAMILLERI, R. S.; COHEN, H.; MACKIE, I. J.; SCULLY, M.; STARKE, R. D.; CRAWLEY, J. T. B.; LANE, D. A.; MACHIN, S. J.

Favourites:
ADD

Free Content A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X
pp. 339-345(7)
Authors: TAI, S. J.; HERZOG, R. W.; MARGARITIS, P.; ARRUDA, V. R.; CHU, K.; GOLDEN, J. A.; LABOSKY, P. A.; HIGH, K. A.

Favourites:
ADD

Free Content Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor
pp. 346-351(6)
Authors: VAN VLIET, H. A. A. M.; BERTINA, R. M.; DAHM, A. E. A.; ROSENDAAL, F. R.; ROSING, J.; MORTEN SANDSET, P.; HELMERHORST, F. M.

Favourites:
ADD

Free Content Variations in fibrinolytic parameters and inhibin-A in pregnancy: related hypertensive disorders
pp. 352-358(7)
Authors: SARTORI, M. T.; SERENA, A.; SAGGIORATO, G.; CAMPEI, S.; FAGGIAN, D.; PAGNAN, A.; PATERNOSTER, D. M.

Favourites:
ADD

Free Content The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities
pp. 359-365(7)
Authors: FRELINGER, A. L.; JAKUBOWSKI, J. A.; LI, Y.; BARNARD, M. R.; LINDEN, M. D.; TARNOW, I.; FOX, M. L.; SUGIDACHI, A.; WINTERS, K. J.; FURMAN, M. I.; MICHELSON, A. D.

Favourites:
ADD

Free Content Immunologic and structural analysis of eight novel domain-deletion β3 integrin peptides designed for detection of HPA-1 antibodies
pp. 366-375(10)
Authors: STAFFORD, P.; GHEVAERT, C.; CAMPBELL, K.; PROULX, C.; SMITH, G.; WILLIAMSON, L. M.; RANASINGHE, E.; WATKINS, N. A.; HUNTINGTON, J. A.; OUWEHAND, W. H.

Favourites:
ADD

Free Content Three novel β3 domain-deletion peptides for the sensitive and specific detection of HPA-4 and six low frequency β3-HPA antibodies
pp. 376-383(8)
Authors: STAFFORD, P.; GARNER, S. F.; HUISKES, E.; KAPLAN, C.; KEKOMAKI, R.; SANTOSO, S.; TSUNO, N. H.; WATKINS, N. A.; OUWEHAND, W. H.

Favourites:
ADD

Free Content Incidence of diagnosis of subsegmental pulmonary emboli using multidetector row and single-detector row computed tomography
pp. 384-386(3)
Authors: NIJKEUTER, M.; KWAKKEL-VAN ERP, J. M.; KRUIP, M. J. H. A.; SOHNE, M.; BÜLLER, H. R.; LEEBEEK, F. W. G.; HUISMAN, M. V.

Favourites:
ADD

Free Content Testing aspirin resistance using the platelet function analyzer-100: some methodological caveats and considerations
pp. 386-388(3)
Authors: MADSEN, E. H.; SCHMIDT, E. B.; GEHR, N.; JOHANNESEN, N. L.; KRISTENSEN, S. R.

Favourites:
ADD

Free Content Type 2M von Willebrand disease: a variant of type 2A?
pp. 388-390(3)
Authors: BATLLE, J.; PÉREZ-RODRÍGUEZ, A.; FRANQUEIRA, M. D.; LÓPEZ-FERNÁNDEZ, M. F.

Favourites:
ADD

Free Content The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1
pp. 393-395(3)
Authors: DAHM, A. E. A.; SANDSET, P. M.; ROSENDAAL, F. R.

Favourites:
ADD

Free Content An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1
pp. 395-397(3)
Authors: JEIMY, S. B.; KRAKOW, E. F.; FULLER, N.; TASNEEM, S.; HAYWARD, C. P. M.

Favourites:
ADD

Free Content Size isn’t everything
pp. 397-399(3)
Authors: KLINE, J. A.; ZEITOUNI, R.; HERNANDEZ-NINO, J.; ROSE, G. A.

Favourites:
ADD

Free Content Invitation to a debate on the serological criteria that define the antiphospholipid syndrome
pp. 399-401(3)
Authors: GALLI, M.; REBER, G.; DE MOERLOOSE, P.; DE GROOT, P. G.

Favourites:
ADD

Free Content Join ISTH
pp. 402-402(1)

Favourites:
ADD

Free Content ANNOUNCEMENTS
pp. 402-403(2)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more